.FDA declines psychedelic MDMA-assisted treatment for post-traumatic stress disorder NBC NewsF.D.A. Downtrends to Accept MDMA Therapy, Looking For More Research The The Big Apple TimesFDA Refuses Ecstasy-Based Medication The Wall Street JournalFDA rejects to approve novel MDMA therapy to handle PTSD, along with request for more litigation information CNNFDA turns down initially psychedelic to treat post-traumatic stress disorder, requiring even more study The Washington Article.